Difference between revisions of "Excerpta Medica"
(→Notes) |
|||
| Line 3: | Line 3: | ||
==History== | ==History== | ||
| + | ==Activities== | ||
| + | The website notes that 'In an earlier version of this case study, we stated that a “company-sponsored journal” was created when in fact this was a “company-sponsored publication”.'<ref>Excerpta Medica [http://www.excerptamedica.com/index.cfm?vID=3CA13C48-1422-16B3-783DC2916631BB46 Case Studies: With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?], accessed 26 August 2009</ref> | ||
==People== | ==People== | ||
Revision as of 11:30, 25 August 2009
|
This article is part of the Pharma_Portal project of Spinwatch. |
Excerpta Medica is a 'strategic medical communications agency'. It 'partners' with its clients in the pharmaceutical and biotech industry to 'educate the global health care community'.[1] It is owned by Elsevier.
Contents
History
Activities
The website notes that 'In an earlier version of this case study, we stated that a “company-sponsored journal” was created when in fact this was a “company-sponsored publication”.'[2]
People
Affiliations
PR and lobbying companies
Patient groups, NGOs
Contact
- Address:
- Phone:
- Email:
- Website:http://www.excerptamedica.com/
Resources
Notes
- ↑ Excerpta Medica Home page, accessed 16 August 2009
- ↑ Excerpta Medica Case Studies: With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?, accessed 26 August 2009
